2Wainberg MA. Perspectives on antiviral drug development. Antiviral Research,2008,1 - 5.
3Wang CH,Hsu YS,Peng CA. Quantum dots encapsulated with amphiphilic alginate as bioprobe for fast screening anti - dengue virus agents. Biosensors and Bioelectronics, 2008,24: 1012 - 1019.
6Hunter R,Younis Y,Muhanji CI,et al. C -2 -Aryl 0 - substituted HI -236 derivatives as non - nueleoside HIV - 1 reverse - transeriptase inhibitors. Bioorg Med Chem,2008,16:10270 - 10280.
5[1]Coffin JM,Hughes SH,Varmus HE. Cold Spring Harbor Laboratory Press 1997.
6[2]Matsuzaki K,Ikeda H,Masuma R,et al.Isochromophilones I and II,novel inhibitors against gp120-CD4 binding produced by Penicillium multicolor FO-2338.I. screening,taxonomy,fermentation,isolation and biological activity[J].J Antibiot,1995,48(7):703-707.
7[3]Matsuzaki K,tahara H,Imokoshi J,et al.New brominated and halogen-less derivatives and structure-activity relationship of azaphilones inhibiting gp120-CD4 binding [J].J Antibiot,1998,51(11):1004-1011.
8[4]Tanaka H,Matsuzaki K,Nakashima H,et al.Chloropeptins,new anti-HIV antibiotics inhibiting gp120-CD4 binding from Streptomyces sp.I.Taxonomy,fermentation,isolation and physico-chemical properties and biological activities [J].J Antibiot,1997,50(1):58-65.
9[5]Singh SB,Jayasuriya H,Salituro GM,et al.The complestatins as HIV-I integrase inhibitors.Efficient isolation,structure elucidation and inhibitory activities of isocomplestatin,chloropeptin I,new complestatins A & B and acid-hydrolysis products of chloropeptin I[J].J Nat Prod,2001,64(7):874-882
10[6]Tsunakawa M,Hu SL,Hoshino Y,et al.Siamycins I and II,new anti-HIV peptides:Fermentation,isolation,biological activity and initial characterization[J].J Antibiot,1995,48(5):433.
